• Breegi Scientific

Breegi Scientific is thrilled to announce that we have been granted Emergency Use Authorization (EUA) for our Negative Pressure SteriDome (NPS) - EUA203100.

With our negative pressure protective barrier enclosure, we will give frontline clinicians a powerful and simple tool for containing the spread of aerosolized infectious disease like COVID-19 in healthcare settings and during airway procedures. NPS weighs only 2 lbs, can be manufactured and shipped at scale, and can be quickly deployed in a few easy steps.

We look forward to the applications of our platform beyond COVID-19 with several patents filed and we are honored to have international interest in the form of funding, manufacturing, and government support for our biocontainment platform.

We would like to thank our amazing team and the countless people around us, our talented and dedicated regulatory, engineering and clinical teams and all those who supported our efforts over the years to achieve this milestone.

A leading medical official praised us for our “thorough research and testing on SteriDome. You and your team set a great example on the importance of patient safety.”

We now embark on the next chapter at Breegi Scientific with even greater resolve to help patients and providers across the globe.

149 views0 comments
  • Breegi Scientific

2020 Quickfire Nurse Innovation Challenge Winner!

Johnson & Johnson is the largest and most diversified healthcare company in the world, supporting innovative companies like Breegi Scieitific with grants and world-class resources. Breegi Scientific was selected in the Nurses Innovate QuickFire Challenge in Maternal and Newborn Health—held in partnership with the Association of Women’s Health, Obstetric and Neonatal Nurses, with a focus on finding innovative solutions for improving neonatal care, obstetrics and women’s health. BSI received $50,000 in funding in addition to mentoring from industry leaders and access to the J-LABS incubator and co-working spaces. BSI is excited to bring our infant incubator NICI to the world with the support of J&J!

134 views0 comments

Updated: Aug 20, 2019

Breegi Scientific’s Neonatal Intensive Care Incubator provides a critical care environment for preventing infant deaths with an ultra-low cost medical device designed for the developing world and other low-resource settings.

Woburn, MA — (ReleaseWire) — 09/08/2017 –Breegi Scientific, Inc. (“BSI”) and Charles H. Hood Foundation’s CH Innovations (“CHI)” announced today a $250,000 investment in BSI. The funds will be used to conduct a thorough clinical assessment of BSI’s novel neonatal intensive care incubator “(NICI)” in Honduras and Zambia and to aid the commercialization efforts of this life-saving medical device.

BSI is developing NICI to address the ongoing infant mortality crisis in the developing world, where more than three million babies die annually due to the lack of access to an incubator environment. The NICI is an ultra-low cost and highly innovative disposable incubator that provides the features of modern intensive care incubators utilized in the most developed nations. “The investment from the Hood Foundation provides a strong corroboration of our team’s effort in developing the NICI over the last three years” said BSI’s founder and CEO, Dr. Wisam Breegi. “This investment will allow us to move rapidly to bring NICI to the millions in need.”

John Parker, a trustee of the Hood Foundation and Managing Director of CHI said “The Hood Foundation is thrilled to support Breegi Scientific’s plans to bring affordable, first-class neonatal care to the vast majority of the world that doesn’t currently have access to such care. Our investment in Breegi Scientific is a great example of how the Hood Foundation’s program-related investment initiative can help advance important pediatric medical solutions through the critical early stages of commercialization. In Dr. Breegi, we have found an incredibly passionate social entrepreneur with the scientific and engineering skills, global network, and enthusiasm and tenacity that is necessary in any effort to improve outcomes of at-risk infants around the world.”

BSI is working with the Honduran Government and Dr. Luther C. Harry, the founder and director of the First Garifuna Hospital of Honduras, for clinical testing and assessment of NICI together with collaborators from Boston University, Northeastern University and Tufts Medical Center.

About Charles H. Hood Foundation and CH Innovations

The Charles H. Hood Foundation is a Boston-based private foundation dedicated to improving the health and quality of life for all children. By identifying innovative pediatric advancements and providing funding in the key stages of development, the Foundation allows high-impact projects to both begin and succeed earlier. The Foundation has a three-pronged approach consisting of Child Health Research Awards, Major Grants, and Program Related Investments (PRIs). The PRI initiative provides critical early support to companies developing important medical solutions for children. Investments are made through the Hood Foundation’s wholly-owned subsidiary CH Innovations, LLC on an impact-first basis.

More information can be found at

79 views0 comments
  • Facebook
  • LinkedIn